NOVEL CYTOTOXIC NATURAL PRODUCTS FROM MARINE SPONGES
来自海洋海绵的新型细胞毒性天然产品
基本信息
- 批准号:2092437
- 负责人:
- 金额:$ 15.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1989
- 资助国家:美国
- 起止时间:1989-04-01 至 1995-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Investigator's Abstract): The project aim is to contribute to
the search of new cancer chemotherapy agents. This research will discover
and study novel marine sponge-derived compounds possessing in vitro
potency against slow growing tumor cells. Cancer assay models are
provided by two collaborators, Dr. Jake Clement of Abbott Laboratories,
and the National Cancer Treatment (NCI-DCT) group, coordinated by Dr. Ven
Narayanan. The long term goals are: (a) to uncover new structural
concepts for cytotoxic active natural products, (b) to employ a concise
approach which involves rapid in vitro assays as a tool to screen extracts
from meagerly explored marine sponge families, (c) to isolate cytotoxic
principles from sponge taxa predicted as being a source of natural
products biosynthesized by symobionts including photosynthetic
microogranisms or heterotrophic bacteria, (d) to efficiently elucidate the
structures of active compounds, (e) to pursue and modify potent cytotoxic
alkaloids discovered during the investigators prior research, and (f) to
forward the most selective in vitro active natural product or
semisynthetic derivatives to the collaborators for in vivo assay follow-up.
An innovative experimental plan is in place to guide this project. Special
emphasis is being devoted to taxa from two sponge orders, Choristida and
Poecilosclerida. The investigator's work to date has shown that sponges of
the former order can be considered as a prime source for novel cytotoxic
alkaloids. The literature provides justification for the belief that
sponges of the latter order are a source of diverse heterocyclics possibly
derived from symbiotic heterotrophic microorganisms. Selected genera from
other sponge orders, which may possess photosynthetic symbionts such as
cyanobacteria, are targeted for investigation because they should yield new
secondary metabolites. Compounds with novel structures will be completely
defined by exhaustive NMR study, computer molecular modeling, and X-ray
examination when suitable crystals can be grown. A part of this project
will be the continuation of studies on sponge products possessing
desirable cytotoxicities. This will involve cytotoxic alkaloids from as
many as eleven structural classes discovered during the investigator's
prior research. Corresponding attention will be given to isolating analogs
and preparing semisynthetic derivatives of these active lead compounds.
描述(调查员的摘要):项目的目的是为
寻找新的癌症化疗剂。 这项研究会发现
并研究具有体外的新型海绵衍生的化合物
针对缓慢生长的肿瘤细胞的效力。 癌症测定模型是
由两个合作者提供,雅培实验室的杰克·克莱门特博士,
由Ven博士协调的国家癌症治疗(NCI-DCT)组
纳拉亚南。 长期目标是:(a)发现新的结构
细胞毒性活性天然产品的概念,(b)采用简洁
涉及快速体外测定作为筛选提取物的工具的方法
从经过少量探索的海洋海绵家族(C)到分离细胞毒性
海绵类群的原则被预测为自然的来源
由Symobionts(包括光合作用)生物合成的产品
微型植物或异养细菌,(d)有效阐明
活性化合物的结构,(e)追求和修饰有效的细胞毒性
在调查人员之前发现的生物碱事先研究,(f)
转发最有选择性的体外活性天然产品或
与合作者进行体内测定后续过程的半合成衍生物。
制定了一个创新的实验计划来指导该项目。 特别的
重点是从两个海绵命令(Choristida)和
Poecilesclerida。 调查员迄今为止的工作表明
以前的顺序可以被视为新型细胞毒性的主要来源
生物碱。 文献为信念提供了理由
后一种海绵是多种杂环的来源
源自共生的异养微生物。 选择的属
其他海绵订单,可能具有光合物共生体,例如
蓝细菌是针对调查的,因为它们应该产生新的
次生代谢产物。 具有新颖结构的化合物将完全
由详尽的NMR研究,计算机分子建模和X射线定义
检查合适的晶体可以种植。这个项目的一部分
将继续对拥有海绵产品的研究
理想的细胞毒性。 这将涉及来自AS的细胞毒性生物碱
许多是在研究者的中发现的11个结构类别
先前的研究。 将给予相应的注意力隔离类似物
并制备这些活性铅化合物的半合成衍生物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Phil Crews的其他基金
Merging Marine-Derived Cytotoxic Natural Products With Experimental Therapeutics
将海洋来源的细胞毒性天然产品与实验疗法相结合
- 批准号:90380799038079
- 财政年份:2015
- 资助金额:$ 15.39万$ 15.39万
- 项目类别:
Baccalaureate Bridge to the Biomedical Sciences Program (ACCESS)
生物医学科学学士学位桥梁课程 (ACCESS)
- 批准号:80196568019656
- 财政年份:2010
- 资助金额:$ 15.39万$ 15.39万
- 项目类别:
Targeted Discovery of Marine-derived Anticancer Leads
海洋源性抗癌先导化合物的靶向发现
- 批准号:79342657934265
- 财政年份:2009
- 资助金额:$ 15.39万$ 15.39万
- 项目类别:
Marine Natural Products 2008 Gordon Research Conference
海洋天然产品2008年戈登研究会议
- 批准号:73886487388648
- 财政年份:2008
- 资助金额:$ 15.39万$ 15.39万
- 项目类别:
Anticancer Leads from Marine Sponges and Marine Fungi
海洋海绵和海洋真菌的抗癌作用
- 批准号:69244836924483
- 财政年份:2005
- 资助金额:$ 15.39万$ 15.39万
- 项目类别:
ACQUISITION OF A VARIAN 600 MHZ HIGH-RESOLUTION NMR: CANCER
采集 VARIAN 600 MHZ 高分辨率 NMR:癌症
- 批准号:69737756973775
- 财政年份:2004
- 资助金额:$ 15.39万$ 15.39万
- 项目类别:
Acquisition of a Varian 600 MHz High-Resolution NMR
获取 Varian 600 MHz 高分辨率 NMR
- 批准号:68037236803723
- 财政年份:2004
- 资助金额:$ 15.39万$ 15.39万
- 项目类别:
ACQUISITION OF A VARIAN 600 MHZ HIGH-RESOLUTION NMR: BIOCHEMISTRY
采集 VARIAN 600 MHZ 高分辨率 NMR:生物化学
- 批准号:69737746973774
- 财政年份:2004
- 资助金额:$ 15.39万$ 15.39万
- 项目类别:
STRUCTURE AND CONFORMATION OF NOVEL ANTITUMOR AGENTS FROM MARINE ANIMALS
海洋动物新型抗肿瘤剂的结构和构象
- 批准号:64308666430866
- 财政年份:2001
- 资助金额:$ 15.39万$ 15.39万
- 项目类别:
相似海外基金
APPROACHES TO CHARACTERIZATION OF ANTIINFECTIVE AGENTS
抗感染剂的表征方法
- 批准号:28860842886084
- 财政年份:1998
- 资助金额:$ 15.39万$ 15.39万
- 项目类别:
APPROACHES TO CHARACTERIZATION OF ANTIINFECTIVE AGENTS
抗感染剂的表征方法
- 批准号:65325966532596
- 财政年份:1998
- 资助金额:$ 15.39万$ 15.39万
- 项目类别:
APPROACHES TO CHARACTERIZATION OF ANTIINFECTIVE AGENTS
抗感染剂的表征方法
- 批准号:63725936372593
- 财政年份:1998
- 资助金额:$ 15.39万$ 15.39万
- 项目类别:
APPROACHES TO CHARACTERIZATION OF ANTIINFECTIVE AGENTS
抗感染剂的表征方法
- 批准号:61684186168418
- 财政年份:1998
- 资助金额:$ 15.39万$ 15.39万
- 项目类别:
APPROACHES TO CHARACTERIZATION OF ANTIINFECTIVE AGENTS
抗感染剂的表征方法
- 批准号:24504442450444
- 财政年份:1998
- 资助金额:$ 15.39万$ 15.39万
- 项目类别: